Dominant mutations in GNAO1, GNB1, and PDE2A have been associated to a complex early-onset neurological disorder characterized by a variable association of hyperkinetic MD, epilepsy, and developmental delay generally evolving into intellectual disability (23, 42, 56). Here, GNAO1 is linked to epilepsy.